Zurcher Kantonalbank (Zurich Cantonalbank) Biomea Fusion, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Oct 25, 2023	BUY	$13.44 - $23.02 $30,132 - $51,610	2,242 Added 89.61%	4,744 $65,000
Q2 2023 Aug 07, 2023	BUY	$21.66 - $41.8 $54,193 - $104,583	2,502 New	2,502 $54,000

Others Institutions Holding BMEA

# of Institutions

104

Shares Held

17.8M

Call Options Held

1.68M

Put Options Held

410K

Cormorant Asset Management, LP Boston, MA

3.57M
Shares

$22.4 Million
2.53% of portfolio
Black Rock Inc. New York, NY

2.34M
Shares

$14.7 Million
0.0% of portfolio
Baker Bros. Advisors LP New York, NY

2.11M
Shares

$13.2 Million
0.23% of portfolio
Vanguard Group Inc Valley Forge, PA

1.4M
Shares

$8.78 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.38M
Shares

$8.66 Million
0.01% of portfolio

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $184M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account